Biden administration is offering COVID-19 Vaccine booster shot for all Americans beginning the week of September 20.
“We have developed a plan to begin offering these booster shots this fall subject to FDA conducting an independent evaluation and determination of the safety and effectiveness of a third dose of the Pfizer (PFE) - Get Free Report and Moderna (MRNA) - Get Free Report vaccines and CDC’s Advisory Committee on Immunization Practices (ACIP) issuing booster dose recommendations based on a thorough review of the evidence," the statement from public health and medical experts from the U.S. Department of Health and Human Services (HHS) read, on Wednesday. "We are prepared to offer booster shots for all Americans beginning the week of September 20 and starting 8 months after an individual’s second dose."
“We also anticipate booster shots will likely be needed for people who received the Johnson & Johnson (J&J) vaccine. Administration of the J&J vaccine did not begin in the U.S. until March 2021, and we expect more data on J&J in the next few weeks. With those data in hand, we will keep the public informed with a timely plan for J&J booster shots as well." they added.
“The data we’ve seen to date suggests the third dose of our vaccine elicits antibody levels that significantly exceed those seen after the two-dose primary schedule. We are pleased to submit these data to the FDA as we continue working together to address the evolving challenges of this pandemic," said Pfizer CEO Albert Bourla, in a statement. “Vaccination is our most effective means of preventing COVID-19 infection – especially severe disease and hospitalization – and its profound impact on protecting lives is indisputable. Still, with the continuing threat of the Delta variant and possible emergence of other variants in the future, we must remain vigilant against this highly contagious virus.”
On Aug. 13, the Centers for Disease Control and Prevention (CDC) approved a third booster shot to immunocompromised Moderna and Pfizer recipients. CDC says that about nine million people are immunocompromised in the U.S.